GlassScriptPhysician profile
Rojan Amjadi
NPI 1942302989
$2,821.61
in general payments reported to CMS, 2019-2025
17 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $333 · 2021: $1,308 · 2022: $324 · 2023: $122 · 2024: $218 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,571.18 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Amarin Pharma, INC. | $277.15 | 2020-2022 | |
| Sientra, INC. | $214.42 | 2019-2022 | |
| Revance Therapeutics, INC. | $201.59 | 2024-2025 | Daxxify |
| Merz North America, INC. | $186.42 | 2019-2025 | Xeomin |
| Amgen INC. | $115.96 | 2019-2021 | |
| Medtronic, INC. | $56.80 | 2024 | V-Loc 180 |
| Dexcom, INC. | $27.71 | 2024 | Dexcom G6 Transmitter |
| Innovation Technologies INC | $23.43 | 2025 | Irrisept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.31 | 2019 | |
| Lilly USA, LLC | $21.99 | 2024 | Jardiance |
| Vertical Pharmaceuticals, LLC | $21.02 | 2024 | Dsuvia |
| Tela Bio, INC. | $20.90 | 2024 | Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $17.30 | 2022 | |
| Allergan, INC. | $15.69 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.87 | 2020 | |
| Coopersurgical, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rojan Amjadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.